1.
J Acquir Immune Defic Syndr
; 54(2): 217-8, 2010 Jun.
Article
in English
| MEDLINE
| ID: mdl-20505474
Subject(s)
Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active/adverse effects , Blood Platelets/drug effects , HIV Infections/blood , Adult , Anti-HIV Agents/adverse effects , Case-Control Studies , Female , HIV Infections/drug therapy , Humans , Male , Platelet Activation/drug effects
2.
Int J Dermatol
; 43(12): 922-4, 2004 Dec.
Article
in English
| MEDLINE
| ID: mdl-15569020
ABSTRACT
Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.
